261700 Screening to identify persistently elevated depression symptoms in urban mothers

Tuesday, October 30, 2012

Yaminette Diaz Linhart, MSW, MPH , Pediatrics, Boston Medical Center/ Boston University School of Medicine, Boston, MA
Emily Feinberg, ScD, CPNP , Department of Community Health Sciences, Boston University School of Public Health, Boston, MA
Michael Silverstein, MD, MPH , Pediatrics, Boston University School of Medicine and Boston Medical Center, Boston, MA
Danielle Appugliese, MPH , Biostatistics, Boston University School of Public Health, Boston, MA
Jenna Sandler, MPH , Pediatrics, Boston Medical Center/ Boston University School of Medicine, Boston, MA
Howard Cabral, PhD, MPH , Biostatistics, Boston University School of Public Health, Boston, MA
Background: Many depression screening instruments are tested to detect concurrent depressive disorders. Given the adverse impact of severe and chronic maternal depressive symptoms on child well-being, it is important to identify if depression screening instruments can also detect persistently elevated depressive symptoms.

Methods: A convenience sample of 181 urban mothers from community sites in the Boston area (WIC offices, Head Start, Early Intervention sites) were screened at baseline for depressive symptoms using the two-item Patient Health Questionnaire (PHQ-2) and assessed monthly for 6 months using a more detailed depressive symptom inventory, the Quick Inventory of Depressive Symptomatology (QIDS). Sensitivity and specificity of the PHQ-2 to detect persistently elevated depressive symptoms were judged against having two or more time points with scores of 14 or above on the QIDS.

Results: At a cutoff score of two, the sensitivity of the PHQ-2 to identify persistently elevated symptoms was 100% and its specificity was 56%. At a cutoff score of three, the sensitivity decreased to 76% and specificity increased 78%.

Conclusion: Using a PHQ-2 cutoff score of two appears to have perfect sensitivity. Using a PHQ-2 cutoff score of three has more balanced sensitivity and specificity to identify persistently elevated depressive symptoms. Because of maternal depression's adverse impacts on children are a function of both severity and chronicity, being able to identify mothers who will likely have persistently elevated depressive symptoms in pediatric or community settings may help clinicians better identify proper referral and treatment mechanisms.

Learning Areas:
Epidemiology
Public health or related research

Learning Objectives:
To evaluate performance characteristics of a short conventionally used depression screening instrument, the two-item Patient Health Questionnaire (PHQ-2) to predict persistently elevated depressive symptoms over a six month period.

Keywords: Screening, Depression

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: As a public health social worker, I have worked to build expertise in conducting research from a practitioner’s perspective to address mental health disparities in urban communities. Currently, I manage an NIMH-funded depression prevention community trial. I have focused on working with mothers with high rates of depression and anxiety through direct service, research, and statewide policy initiatives. My goal is to increase the well-being of women and children through public health initiatives.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.